| Product Code: ETC368904 | Publication Date: Aug 2022 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
India`s pulmonology devices import shipments in 2024 saw significant contributions from top exporting countries such as China, Australia, Germany, UK, and Metropolitan France. The market displayed a low concentration level, with the Herfindahl-Hirschman Index (HHI) decreasing from very low in 2023 to low in 2024. Despite a negative compound annual growth rate (CAGR) of -8.64% from 2020 to 2024, there was a positive growth rate of 5.19% from 2023 to 2024, indicating a potential turnaround in the industry`s performance.

The pulmonary devices market size was estimated at US$ 1 billion in 2025 and is expected to witness significant growth over the years driven by factors such as increasing awareness about respiratory disease management combined with a rising geriatric population that necessitates specialized care along with advancing technology which has made it easier to diagnose COPD/Asthma related diseases quickly. Furthermore, rapid urbanization leading to a higher prevalence of air pollution due to other factors which can cause health issues related to the lungs is creating new opportunities within the pulmonology devices market space.
The pulmonology devices market in India is witnessing significant growth due to multiple drivers. One of the primary drivers is the rising prevalence of respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea. The increasing urbanization, pollution, and lifestyle changes contribute to the high burden of respiratory conditions in India. As a result, there is a growing demand for pulmonology devices, such as spirometers, nebulizers, and CPAP machines, to diagnose and manage respiratory illnesses effectively. Additionally, the government`s initiatives to improve healthcare infrastructure and increase awareness about respiratory health further support the market`s growth. The introduction of advanced and user-friendly pulmonology devices has also increased their adoption, especially in private healthcare settings. Moreover, the ongoing research and development activities in medical technology, coupled with the entry of multinational medical device companies in the India market, are driving innovation and competition, leading to improved accessibility and affordability of pulmonology devices across the country.
The pulmonology devices market in India has experienced growth, driven by factors like the increasing prevalence of respiratory diseases and the aging population. However, the market faces challenges. The high cost of advanced pulmonology devices, such as ventilators and pulmonary function testing equipment, may limit their accessibility, particularly in rural and economically disadvantaged areas. The need for regular maintenance and calibration of pulmonology devices can also be a challenge for smaller healthcare facilities with limited resources. Moreover, the uneven distribution of healthcare infrastructure across the country may impact the availability of specialized pulmonology devices in certain regions.
The pulmonology devices market in India experienced significant impacts due to the COVID-19 pandemic. As the country faced a surge in COVID-19 cases, there was a heightened demand for respiratory care equipment and devices. However, disruptions in the supply chain and manufacturing processes, as well as logistic challenges during lockdowns, hindered the smooth functioning of the pulmonology devices market. Despite the challenges, the pandemic also accelerated the adoption of telemedicine and remote patient monitoring solutions, providing opportunities for market players to explore innovative ways to deliver respiratory care to patients in need.
The pulmonology devices market in India has experienced substantial growth, driven by an increase in respiratory diseases and the demand for advanced diagnostic and treatment solutions. Key players in this market include ResMed India, Philips India, Medtronic India, and GlaxoSmithKline India. These companies offer a wide range of pulmonology devices, including continuous positive airway pressure (CPAP) machines, nebulizers, and spirometers, catering to the needs of patients and healthcare providers. They focus on continuous research and development to introduce innovative and user-friendly devices that improve patient outcomes. Key players also collaborate with respiratory care specialists, hospitals, and healthcare clinics to provide training and support, ensuring the effective use of pulmonology devices across India.